logo

Health News

Share SHARE
Jesus-is-So-Cool-062316-lg.jpg

There are risks associated with getting a tattoo, according to the U.S. Food and Drug Administration. There are increasing reports of people developing infections from contaminated tattoo inks and having bad reactions to the inks, according to Dr. Linda Katz, director of the FDA's Office of Cosmetics and Colors.
More
Most children who suffer concussions receive treatment for the condition with their primary physicians, not at the ER, according to a new study from researchers at the Children's Hospital of Philadelphia. This data could provide new insight in the perceived incidence rates of childhood concussions in the U.S.
More
Chronic marijuana use may be linked with an increased risk of periodontal issues, according to a new study from researchers in Dunedin, New Zealand. For the study the researchers enlisted 1,000 people starting in 1972 and 1973 who were followed for 38 years. Each of the participants were asked to self-report their levels of cannabis usage at the ages of 18, 21, 26, 32 and 38. The number of sexual encounters between same sex pairs have doubled in the U.S., according to a news study which collected research from the National Social Survey. The study collected data from 30,000 sexually active individuals between the years of 1973 and 2014. They found that the number of people reporting sexual encounters with the same sex doubled between 1990 and 2014. The first ever successful penis transplant has taken place in the United States. The man, 64-year-old Thomas Manning of Halifax, Massachusetts, received the transplant over the course of a 15-hour surgery between May 8 and 9 in Boston. Manning was forced to have his penis removed due to cancer and doctors say they are "cautiously optimistic" that the surgery was successful. More
The drug pregabalin, commonly used to treat pain, epilepsy, anxiety and other brain health disorders, may be associated with an increased risk of major birth defects, according to a new study. The study, published in Neurology, the medical journal of the American Academy of Neurology, featured information collected in seven countries from 164 women who took pregabalin during a pregnancy. More
mans-feet-062316.jpg

Study Says Skin Cancer Can Be Found On Soles Of Your Feet



Damage caused by walking or running could promote melanoma on the soles of the feet, a new study shows. The study, published in the New England Journal of Medicine, reviewed the medical data between January 1990 and December 2014 revealed 123 patients at Shinshu University Hospital of people who had been diagnosed with melanoma on the soles of their feet.
More

New Synthetic Drug Linked To Dozens Of Deaths



A new synthetic drug named U-47700 has been linked to over 50 deaths across the U.S. The drug, an opioid painkiller nearly eight times stronger than morphine, can be readily purchased online. Several states, including Georgia, Ohio and Wyoming have taken steps to prevent the purchase and sale of U-47700, with Kansas law enforcement agencies seeking an emergency ban.
More

More American Men Being Diagnosed With Parkinson's



The rise in Parkinson's disease rates in men over the past three decades may be tied to a decrease in smoking rates, according to a new study. The study, published online in the journal JAMA Neurology, showed that rates of Parkinson's disease nearly doubled for men between 1996 and 2005, and the increase was steepest for men aged 70 and older.
More




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/25/16AMGNABP 501 (BLA)FDA decision on ABP 501 as a biosimilar to AbbVie’s immunosuppressant Humira
09/25/16AMGNABP 501 (BLA)FDA decision on ABP 501 for the treatment of plaque psoriasis, rheumatoid Arthritis
09/25/16PTIEREMOXY (Resubmitted NDA)FDA decision on REMOXY for patients with moderate-to-severe chronic pain
09/25/16DRRXREMOXY (Resubmitted NDA)FDA decision on REMOXY for patients with moderate-to-severe chronic pain
09/15/16DVAXHEPLISAV-B (BLA)FDA decision on HEPLISAV-B for immunization against hepatitis B infection in adults 18 years of age and older
09/14/16ARLZYOSPRALA (Resubmitted NDA)FDA decision on YOSPRALA for secondary prevention of cardiovascular disease
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data